Trident Lifeline

77
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MKA01014
  • NSEID:
  • BSEID: 543616
INR
305.00
0.00 (0.00%)
BSENSE

Dec 05

BSE+NSE Vol: 600

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
Operating Income
86.00
44.00
31.00
21.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
Net Sales
86.00
44.00
31.00
21.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
-2.00
0.00
Raw Materials Consumed
44.00
30.00
23.00
14.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
Employee Cost
12.00
2.00
1.00
1.00
Operating Expenses
6.00
2.00
2.00
1.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1.00
0.00
0.00
1.00
Cost of Software developments
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
Total Expenditure
72.00
36.00
25.00
18.00
Operating Profit (PBDIT) excl Other Income
14.00
8.00
6.00
2.00
Other Income
8.00
2.00
1.00
0.00
Operating Profit (PBDIT)
23.00
10.00
7.00
3.00
Interest
3.00
0.00
0.00
0.00
Profit before Depriciation and Tax
19.00
9.00
6.00
3.00
Depreciation
5.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
13.00
8.00
6.00
3.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
Profit Before Tax
13.00
8.00
6.00
3.00
Provision for Tax
3.00
2.00
0.00
0.00
Profit After Tax
10.00
5.00
6.00
2.00
Extraordinary Items
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
Profit Balance B/F
9.00
2.00
-3.00
-5.00
Profit Available for appropriations
21.00
8.00
2.00
-3.00
Appropriations
21.00
8.00
2.00
-3.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
10.22
5.52
6.22
3.94
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 94.86% vs 40.82% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 81.44% vs 31.03% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 559.36% vs 29.73% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 76.69% vs -1.31% in Mar 2024

Compare Profit and Loss Results of Trident Lifeline
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
86.00
155.00
-69.00
-44.52%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
86.00
155.00
-69.00
-44.52%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-6.00
6.00
100.00%
Raw Materials Consumed
44.00
123.00
-79.00
-64.23%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
12.00
7.00
5.00
71.43%
Operating Expenses
6.00
0.00
6.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
2.00
-1.00
-50.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
3.00
-2.00
-66.67%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
72.00
139.00
-67.00
-48.20%
Operating Profit (PBDIT) excl Other Income
14.00
16.00
-2.00
-12.50%
Other Income
8.00
2.00
6.00
300.00%
Operating Profit (PBDIT)
23.00
18.00
5.00
27.78%
Interest
3.00
3.00
0.00
0.00%
Profit before Depriciation and Tax
19.00
14.00
5.00
35.71%
Depreciation
5.00
3.00
2.00
66.67%
Profit Before Taxation & Exceptional Items
13.00
11.00
2.00
18.18%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
11.00
2.00
18.18%
Provision for Tax
3.00
3.00
0.00
0.00%
Profit After Tax
10.00
7.00
3.00
42.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
9.00
28.00
-19.00
-67.86%
Profit Available for appropriations
21.00
36.00
-15.00
-41.67%
Appropriations
21.00
36.00
-15.00
-41.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
10.22
5.6
4.62
82.50%
Profit And Loss - Net Sales
Net Sales 86.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 94.86% vs 40.82% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.86 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 81.44% vs 31.03% in Mar 2024

Profit And Loss - Interest
Interest 3.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 559.36% vs 29.73% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.49 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 76.69% vs -1.31% in Mar 2024